Roquette, a global provider of plant-based ingredients and pharmaceutical and nutraceutical excipients, introduced three new product grades for its range of excipients for moisture protection at CPHI Barcelona. The portfolio offers enhanced stability and moisture protection for sensitive formulations, as well as a comprehensive range of low water activity (Aw) excipients, suitable for any manufacturing method or dosage form, according to the company.

The efficacy and stability of moisture sensitive active ingredients, such as probiotic strains, dabigatran (an anti-coagulant), tiotropium (a medication used in the treatment of chronic obstructive pulmonary disease [COPD]) and many more, can be negatively affected by the presence of excess water within the formulation. Moisture management has in the past had to give way to other critical considerations, such as flowability, compactability or homogeneity, leading manufacturers to select excipients, which require a lengthy additional drying process. 

In recent years, specialized excipients have emerged to streamline and expedite the processing of moisture sensitive active pharmaceutical and nutraceutical ingredients, but these solutions are often specific to a particular delivery format or processing method, denying manufacturers complete freedom. In response to this issue, Roquette aims to innovate without limits with the launch of its complete moisture sensitive excipients portfolio.